Summary Except for gallstones, the risk factors for cancers of the biliary tract (CBTs) are poorly understood. Recent case-control studies have suggested cigarette smoking as a potential risk factor. In a cohort study of nearly 250 000 US veterans whose mortality was followed for up to 26 years, we evaluated the risk of CBT associated with tobacco use. Relative risks (RRs) and corresponding 95% confidence intervals (CIs) were calculated. A total of 303 CBT deaths were observed during the follow-up period. Compared with those who had never used any tobacco, current cigarette smokers at entry to the cohort had a 50% excess risk of CBT (RR= 1.5, CI = 1.1-2.0). A nearly 2-fold risk was observed among those who smoked more than 20 cigarettes per day and among those who started smoking under age 20. Non-significant increases in risk occurred among smokers of other forms of tobacco. This cohort study is consistent with reports that smoking is a risk factor for CBT, but further studies are needed to clarify whether the effect is specific for certain subsites and whether it reflects an association with pre-existent gallstones.
Cancers of the biliary tract (CBT) encompass malignant tumours arising from the gallbladder, extrahepatic bile ducts and ampulla of Vater. These tumours are relatively uncommon, accounting for less than 1% of all incident cancers in the US (Ries et al., 1994) . Because of their rarity, risk factors have not been well examined. However, an association with antecedent gallstones is clearly established (Diehl, 1983; Lowenfels et al., 1985; Maringhini et al., 1987) , along with obesity and high parity among women (Yen et al., 1987; Zatonski et al., 1992; Chow et al., 1994; Moerman et al., 1994a ). An increased risk of CBT has been associated with cigarette smoking in a few recent case-control studies (Ghadirian et al., 1993; Chow et al., 1994; Moerman et al., 1994b) , but not in another study of cancer of the extrahepatic bile duct (Yen et al., 1987) . To examine further the role of cigarette smoking on CBT risk, we evaluated CBT mortality in a cohort of US veterans followed for up to 26 years. smokers are based solely on information obtained in 1954/ 1957. Included in the analysis were 248 046 veterans (84% of the cohort) who responded to the questionnaires. The mortality of cohort members was ascertained until September 30, 1980, with about 96% completeness of ascertainment. Death certificates were obtained for 95% of the deceased veterans.
Causes of death were coded using the Seventh Revision of the International Statistical Classification of Diseases (ICD7) (WHO, 1957) . In earlier reports on this cohort, CBT (ICD7 code 155.1) was not examined separately (Dorn, 1959; Kahn, 1966; Rogot and Murray, 1980) . In the present analysis, the associations between CBT and tobacco use were assessed by relative risks (RRs) and corresponding 95% confidence intervals (CIs), using a Poisson regression program for modelling hazard functions with grouped data (Preston et al., 1985) . RRs were adjusted for age and calendar time periods in 5 year intervals.
Materials and methods
Details of the cohort and methods of follow-up have been reported elsewhere (Dorn, 1959; Kahn, 1966; Rogot and Murray, 1980; McLaughlin et al., 1990 A total of 303 CBT deaths among cohort respondents was reported during the study period. Current smokers (in 1954 or 1957) had a significant 50% excess risk of CBT (RR = 1.5, CI = 1.1-2.0) compared with those who had never used any tobacco (Table I ). In addition, non-significant excess risks were observed among former cigarette smokers (RR = 1.2, CI = 0.8-1.8), smokers of pipes/cigars only (RR = 1.4, CI = 0.9-2.2), and 'other' smokers (RR = 1.4, CI = 0.9-2.0), most of whom were former cigarette smokers who currently smoked cigars/pipes (Table I) .
Among current cigarette smokers, a nearly 2-fold risk of CBT (RR = 1.8, CI = 1.2-2.7) was associated with smoking more than 20 cigarettes per day, although the dose-response trend (P <0.05) with amount of cigarette consumption was not smooth (Table II) 
Discussion
The relation of tobacco smoking to CBT has been examined in a few small case-control studies. Among the findings are an excess risk of CBT among smokers who did not drink alcohol (Moerman et al., 1994b) , a 3-fold risk of extrahepatic bile duct cancers among heavy smokers (Chow et al., 1994) , a small excess risk of gallbladder cancer and a nearly 3-fold risk of extrahepatic bile duct cancer among smokers of nonfiltered cigarettes (Ghadirian et al., 1993) . However, an inverse association between cigarette smoking and risk of CBT was reported in an earlier hospital-based study (Yen et al., 1987) , in which controls might be more likely to have smoked than the general population.
In this attempt to examine the association between tobacco use and CBT employing a cohort study design, we found a small excess risk among cigarette smokers and a suggestive dose-response relationship with amount of smoking and age started smoking. Our results provide further evidence linking smoking and CBT, although the risk estimates are lower than those reported in recent case-control studies (Ghadirian et al., 1993; Chow et al., 1994; Moerman et al., 1994b) .
A limitation of our study is that information on smoking habits was available only for 1954/1957 . If the smoking patterns in this cohort of veterans resemble those of American men in general, over 40% of those smoking then may have stopped smoking during the 26 years of follow-up (US Surgeon General, 1989) . Therefore, the risks of CBT associated with cigarette smoking may be underestimated in our study, as a result of the misclassification of ex-smokers as current smokers. The misclassification in duration of smoking also may have precluded the detection of a dose-response relation with risks.
Another limitation is that medical records were not obtained for cases in this study. However, in a previous study conducted to examine the accuracy of US cancer mortality data, 86.5% of CBT reported on death certificates was confirmed by hospital records (Percy et al., 1981) . In addition, we could not evaluate risk of CBT by anatomic subsite since these tumours were not coded separately in ICD7, so more detailed studies are needed. It is also important to evaluate information on other risk factors, including gallstones, which have been linked to smoking in some studies (McMichael et al., 1992; Grodstein et al., 1994) . Excess gallstone risks of 30% to 2-fold have been observed among smokers, particularly among women (Baron and Logan, 1990; McMichael et al., 1992; Grodstein et al., 1994) . Future studies should examine whether smoking affects CBT risks directly by a carcinogenic effect or indirectly by an association with gallstones.
In summary, this cohort study suggests that cigarette smoking is a weak risk factor for CBT. Additional studies of CBT are needed to clarify the effects of smoking on subsites of the biliary tract and to identify the mechanisms by which smoking may be related to CBT.
